GH1 and metabolic syndrome: Based on the above, this retrospective monocentric observational study aimed to estimate the prevalence and severity of metabolic comorbidities (diabetes, hypertension, and dyslipidemia) in surgically treated acromegalic patients with disease control and concordant or discordant GH/IGF-1 levels.